Compare

HeartBeam, Inc. vs QTREX Quantum Ltd. vs Biotricity Inc. vs Bluejay Diagnostics, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearHeartBeam, Inc.
BEAT
QTREX Quantum Ltd.
QTEX
Biotricity Inc.
BTCY
Bluejay Diagnostics, Inc.
BJDX
Year ended2025-12-312025-12-312026-03-312025-12-31
Revenuen/a$289.0K$16.00Mn/a
Revenue growth (YoY)n/an/a+16.0%n/a
Gross marginn/a0.7%80.9%n/a
Operating marginn/an/m10.6%n/a
Net marginn/an/m-15.0%n/a
Net income-$21.02M-$13.22M-$2.40M-$6.85M
EPS (Diluted)-$0.62-$0.45-$0.12-$15.25
Operating cash flow-$13.99M-$9.86M-$719.0K-$6.05M
Free cash flow-$14.59M-$9.96Mn/a-$6.23M
Cash & equivalents$4.38M$3.16M$149.8K$5.16M
Total assets$5.84M$5.34M$6.45M$7.12M
Total liabilities$3.24Mn/a$39.41M$1.14M
Shareholders' equity$2.60M$2.32M-$34.68M$5.98M
Return on year-end equity-807.3%-569.1%n/a-114.6%
Shares outstanding26.96M35.95M28.60M604.5K

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearHeartBeam, Inc.QTREX Quantum Ltd.Biotricity Inc.Bluejay Diagnostics, Inc.
Latestn/a$289.0K
Ended 2025-12-31
$16.00M
Ended 2026-03-31
$249.0K
Ended 2022-12-31
1 year earliern/a$0
Ended 2024-12-31
$13.79M
Ended 2025-03-31
n/a
2 years earliern/a$0
Ended 2023-12-31
$12.06M
Ended 2024-03-31
n/a
3 years earliern/an/a$9.64M
Ended 2023-03-31
n/a
4 years earliern/an/a$7.65M
Ended 2022-03-31
n/a